MCRB
MCRB
NASDAQ · Biotechnology

Seres Therapeutics Inc

$3.47
-0.05 (-1.42%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +641.5% upside
Low Target $18.91
Average Target $25.73
High Target $33.51
Current Price $3.47
Current
$3.47
Target
$25.73
$18.91 $25.73 avg $33.51
Scenario Analysis
Bear Case
$18.91
445.0%
Low target
Base Case
$25.73
+641.5%
Avg target
Bull Case
$33.51
+865.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$29.98
-88.4% from high
52-Week Low
$3.52
+-1.4% from low
Target vs 52W High
$25.73
-14.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%